Diabetes & Endocrinology Perspective

 
 
  • Tackling Amiodarone-Induced Hyperthyroidism What should be done in cases of amiodarone-induced hyperthyroidism? A conversation with Igor Tauveron and Boris Hansel.
  • Refer Medicare Patients for Free Diabetes Prevention Program   A new Medicare benefit can help patients prevent diabetes and improve other aspects of their health, says Dr Anne Peters.
  • Will ODYSSEY Clear Hurdles for PCSK9 Inhibitor Access?   Drs Budoff and Baum discuss the topline results of the ODYSSEY trial presented at the 2018 ACC meeting and hope for easier access to PCSK9 inhibitors for their high-risk patients.
  • 'What Are These Bumps I See All Over?' How would you approach a patient who comes to the primary care clinician with worries about bumps on her buttocks and knees?
  • Ketogenic Diet: Which Patients Benefit? Long a treatment for epilepsy, ketogenic diets are being studied for conditions ranging from cancer to diabetes.
  • Women's Hearts: How Women Can Walk Away From Heart Failure   Dr JoAnn Manson describes findings of a recent study showing that walking farther and faster can prevent heart failure in women.
  • Anatomy of a Research Project: From Idea to Publication Ever wonder how a medical study got its start? A researcher shares his personal journey.
  • ACC 2018Sanjay Kaul Grades Four Big Trials From ACC 2018 Dr Kaul rates trials on alirocumab, black barbershop-based healthcare, canakinumab, and the wearable cardioverter defibrillator, from the 2018 American College of Cardiology Scientific Sessions.
  • Preventing Hip Fractures: Have We Encountered a Perfect Storm?   Dr Andrew Kaunitz sees a worrying state of affairs as trends in incidence, diagnosis, and treatment converge to put menopausal women at risk for hip fractures.
  • The Future of Medicine From a Leader in Biosensors   Dr Eric Topol talks with pioneering researcher John Rogers about how his flexible electronic devices are being used in medicine and what further developments lie ahead.
  • DUPC 2018 Read clinically focused news coverage of key developments from DUPC 2018
  • Will Physicians Ever Adopt Obesity Drugs? A new Medscape survey shows that prescribers are still skeptical about FDA-approved medications to help obese patients lose weight.
  • More Positives for PCSK9 inhibitors and the LDL-C Hypothesis   The co-investigator for the ODYSSEY study of alirocumab discusses which patients will benefit most from the expensive biologic and why the mortality reduction finding comes with qualifiers.
  • ACC 2018 MOMENTUM-3: The Future of the LVAD Is Here and Now A trial showing better outcomes for HeartMate 3 over HeartMate II sends Dr Walton-Shirley down memory lane to recall the patients she has referred for implantation of a left ventricular assist device (LVAD).
  • Statins in the Elderly: Evidence-Based or Not? What does the evidence show, and is it enough to guide decisions about statins for older adults?
  • SGLT2 Inhibitors in Type 1 Diabetes Are SGLT2 inhibitors safe and effective in patients with type 1 diabetes?
  • ENDO 2018 Read clinically focused news coverage of key developments from ENDO 2018.
  • Irreproducible 'Scientific' Results   Irreproducible results published in journals are misleading, irresponsible, and costly, and it is up to researchers and publishers to resolve this problem now.
  • ENDO 2018: What to Expect It's a meeting where nobodies rub elbows with somebodies, camaraderie is created, and the quantity of ideas proves that endocrinologists are 'pretty worthy people,' says Dr Richard Plotzker.
  • The State of the Art in Cardiovascular Risk Reduction Dr Williams provides an overview of the latest information on cardiovascular risk reduction, from the American College of Cardiology.